Actinium Pharmaceuticals, Inc. (Delaware)Actinium Pharmaceuticals, Inc. (Delaware)Actinium Pharmaceuticals, Inc. (Delaware)

Actinium Pharmaceuticals, Inc. (Delaware)

No trades
See on Supercharts

Price target

5.000.000.00%
The 5 analysts offering 1 year price forecasts for ATNM have a max estimate of — and a min estimate of —.

Analyst rating

Based on 5 analysts giving stock ratings to ATNM in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


ATNM EPS for the last quarter is −0.37 USD despite the estimation of −0.39 USD. In the next quarter EPS is expected to reach −0.37 USD. Track more of Actinium Pharmaceuticals, Inc. (Delaware) financials and stay on top of what is up with the company.
In the next quarter Actinium Pharmaceuticals, Inc. (Delaware) revenue is expected to reach 0.00 USD. Check out Actinium Pharmaceuticals, Inc. (Delaware) revenue and earnings and make informed decisions.
According to analysts, ATNM price target is 5.00 USD with a max estimate of 9.00 USD and a min estimate of 2.00 USD. Check if this forecast comes true in a year, meanwhile watch Actinium Pharmaceuticals, Inc. (Delaware) stock price chart and keep track of the current situation with ATNM news and stock market news.
We've gathered opinions of 5 analysts rating ATNM stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.